Erschienen in:
02.09.2019 | Case Report
Synchronous Inflammatory Myofibroblastic Tumour of Liver and Carcinoma Head of Pancreas in a Young Male: a Diagnostic Dilemma
verfasst von:
Kanwalpreet Kaur, Rajni Yadav, Nihar Ranjan Dash, K. S. Madhusudan, Kirti Jangra, Prasenjit Das, Siddhartha Dattagupta
Erschienen in:
Journal of Gastrointestinal Cancer
|
Ausgabe 2/2020
Einloggen, um Zugang zu erhalten
Excerpt
Inflammatory myofibroblastic tumour (IMT) is a fibroblastic and myofibroblastic neoplasm of intermediate biological potential because of its tendency for local recurrence and rare incidence of metastasis [
1]. This distinctive neoplasm is composed of myofibroblastic cells accompanied by an inflammatory infiltrate of plasma cells, lymphocytes, and eosinophils. It is extremely rare in the liver and was first described by Pack and Baker in 1953 [
2]. The true incidence has still not been reported in the literature. However, the postulated incidence is as low as 0.7% [
3]. IMT of the liver is challenging to diagnose not only due to low incidence but also because of non-specific clinical, laboratory, or radiological features. Diagnosis mainly relies on the histopathological examination. …
